Doc's note: Today, I want to introduce you to Josh Baylin. Josh has a unique background and skill set... He has operated at the highest levels of tech and Wall Street for 25 years and even given expert testimony to congressional committees.

I did everything in my power to recruit Josh and to make his remarkable, new Shadow Data Indicator accessible to the folks who need it most. His indicator offers powerful hedge-fund-style research to average folks.

And in today's issue, Josh details a truth about investing that even big institutions often miss...

I was the first person in line for the iPhone. Period. Nobody was in front of me.

In June 2007, most of Wall Street thought the Apple iPhone would be a flop. One analyst forecasted that the company would ship maybe a million units that year.

Back then, I worked for SAC Capital – one of the largest hedge funds in the world at the time. And I was pushing Apple relentlessly...

"Do you have any other ideas?" they'd ask.

"No," I said. "Apple is my only idea."

I walked into a meeting and said Apple wouldn't sell 1 million iPhones, but 1 billion. I was laughed out of the room.

But I had stood in that line. I had watched a hundred people queue up behind me. And I had seen their faces when they held a smartphone for the first time.

This device was going to consume everything in its path.

And I knew it well before Wall Street – because I understood a truth about investing that even big institutions often miss...

Recognize Advancements Before Wall Street Does

Three years earlier, I predicted the iPhone's existence while testifying before Congress...

I knew there would be a convergence – that cameras, music players, phones, and computers would collapse into a single device.

It wasn't a prophecy. It was observation.

I had felt the friction of five devices in my pockets. I knew someone would solve it. The numbers came later – the signal came first.

And this principle has driven every great trade of my career...

Truth reveals itself in behavior, long before it's seen in reports.

Almost every investor waits for the financial results. But that's almost always too late. It comes down to the natural sequence of events...

  1. Something shifts in the real world.
  1. People behave differently.
  1. Observable signals appear.
  1. Institutions notice much later.
  1. Financial results confirm what was already visible.
  1. Markets adjust.

You don't have to wait for Wall Street to confirm what you see on your own.

The Advantage of Observable Signals

I learned this firsthand at SAC Capital...

Before the iPhone, I was tracking gaming consoles in 2006. Sony had just sold 100 million PlayStation 2 consoles... So it priced PlayStation 3 developer kits (or "dev kits") at $15,000.

A dev kit is a type of gaming console that developers use to create and test their own video games. More dev kits mean more games on the way... And more games mean more console sales.

But while Sony was charging developers a premium, Nintendo priced its Wii dev kits at a fraction of that total after its GameCube console flopped.

We monitored every online message board, tracking developer interest. The signal was unmistakable: Developers were flocking to the Wii.

By the time Wall Street figured out Sony was in trouble, we had already positioned ourselves.

The developer kits told us the truth months before the earnings reports did.

It was the same as the iPhone in 2007. And I used this principle again in 2020...

Before the world had fully shut down from COVID-19, analysts were still debating whether home fitness was a fad. So I bought a Peloton – not to trade it, but to ride it.

With each delivery, Peloton sends someone to set up your new equipment. Before the installer left, I asked him, "What's your day like?"

He told me, "I'm installing all day for weeks."

One sentence told me more than any earnings model could. I bought the stock at $19 and held on as it soared to more than $130 per share.

The signal changed each time – from game-developer web posts, to a line outside the Apple store, to an installer's calendar. But the principle stayed the same.

The Market's Blind Spot Is Creating New Opportunities

So why doesn't everyone use behavioral signals?

First, institutions are built around reporting, not observation.

They need documentation, process, and committees. They can't act on someone's impression from standing in line for a product release. And by the time their spreadsheets are ready, the trade is over.

Second, interpreting behavior requires knowledge.

Signals only matter when you understand the world they come from. That's why investing legend Warren Buffett always advised, "Invest in what you know." And it's why institutions don't often stray outside their comfort zone.

Third, deep observation doesn't scale.

A portfolio manager keeping track of 40 stocks can't afford to watch Reddit boards for hours. This approach works best for independent thinkers – not industrial analysts.

For all these reasons, you can use behavioral analysis to your advantage. It's a paradox of today's investing world...

Thanks to the Internet, behavior leaves more breadcrumbs than ever. The volume of observable information is exploding... But people are still overlooking it.

The information edge no longer comes from access. It comes from attention. And the gap between what's visible and what's actually analyzed will create a new generation of investment opportunities.

The signals are public. The interpretation is the craft... And the opportunity belongs to anyone willing to look closely enough.

Good investing,

Josh Baylin

Editor's note: Josh predicts the current market upheaval will likely spell disaster for many.

Of course, it will also open a rare wealth-building opportunity for those who understand what's really happening... The next move is up to you.

To get your money on the right side of this chaotic moment in history, click here.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top